Veru Inc. (VERU) CEO Mitchell Steiner on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/12/20
Veru Announces Positive Top-Line Interim Data from Phase 2 Clinical Trial of Zuclomiphene to Treat Hot Flashes in Men with Prostate Cancer on Androgen Deprivation TherapyGlobeNewsWire • 01/13/20
Veru Inc. (VERU) CEO Mitchell Steiner on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 12/12/19
Veru Announces Full Enrollment of Phase 2 Trial in Men with Prostate Cancer Treatment Induced Hot FlashesGlobeNewsWire • 10/02/19
Veru to Participate at Three Upcoming Healthcare Investor Conferences in New YorkGlobeNewsWire • 08/28/19
Veru to Ring NASDAQ Closing Bell on September 4th to Kick Off National Prostate Cancer Awareness MonthGlobeNewsWire • 08/27/19
Veru Inc. (VERU) CEO Mitchell Steiner on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/08/19
Veru Inc. (VERU) CEO Mitchell Steiner on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/16/19
Veru (VERU) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseZacks Investment Research • 05/01/19